Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients.

Olga Millán Pablo RuizVirginia FortunaMiquel Navasa Mercè Brunet

Published in: Liver international : official journal of the International Association for the Study of the Liver (2020)

Sequential post-transplantation NFAT-RGE monitoring combined with intralymphocytary IL-2 and IFN-γ before transplantation and at the first and third month post-transplantation may be key predictive and diagnostic biomarkers for the risk of TCMAR and SCR and better guide CNi therapy in LT patients.

Keyphrases

nuclear factor
end stage renal disease
toll like receptor
cell therapy
ejection fraction
chronic kidney disease
newly diagnosed
liver failure
dendritic cells
climate change
bone marrow
kidney transplantation
patient reported
mechanical ventilation